Quadrant Capital Group LLC Novo Nordisk A S Transaction History
Quadrant Capital Group LLC
- $1.43 Billion
- Q4 2024
A detailed history of Quadrant Capital Group LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Quadrant Capital Group LLC holds 35,393 shares of NVO stock, worth $2.12 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
35,393
Previous 38,199
7.35%
Holding current value
$2.12 Million
Previous $4.55 Million
33.07%
% of portfolio
0.21%
Previous 0.32%
Shares
30 transactions
Others Institutions Holding NVO
# of Institutions
1,861Shares Held
336MCall Options Held
11.9MPut Options Held
10.6M-
Jennison Associates LLC19.9MShares$1.19 Billion1.06% of portfolio
-
Bank Of America Corp Charlotte, NC15.5MShares$928 Million0.11% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL13MShares$779 Million1.67% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$757 Million0.44% of portfolio
-
Morgan Stanley New York, NY12.2MShares$731 Million0.08% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $135B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...